InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (5 ops.)
Explore the detailed record of transactions filed by Christensen Jamie, Directeur Scientifique. Officer active across 1 companies, notably Mirati Therapeutics, Inc.. Aggregated, 11 filings have been logged. Total volume traded: €524k. The latest transaction was disclosed on 23 May 2022 — Cession. Regulator: SEC (Form 4). All data is free.
Declarations11 total
€37,117624 shares@ €59.4837.1% of flow
Common Stock
SEC:0001214659-22-008031:0·
010,755 shares0
Common Stock
SEC:0001214659-22-000857·
010,755 shares0
Common Stock
SEC:0001214659-22-000857:0·
€188,4731,442 shares@ €130.702877.4% of flow
Common Stock
SEC:0001214659-22-000418·
€188,4731,442 shares@ €130.702836.0% of flow
Common Stock
SEC:0001214659-22-000418:0·
019,149 shares0
Common Stock
SEC:0001214659-21-013377·
019,149 shares0
Common Stock
SEC:0001214659-21-013377:0·
06,856 shares0
Common Stock
SEC:0001214659-21-012820·
06,856 shares0
Common Stock
SEC:0001214659-21-012820:0·
€54,965435 shares@ €126.356622.6% of flow
Common Stock
SEC:0001214659-21-005911·
€54,965435 shares@ €126.356610.5% of flow
Common Stock
SEC:0001214659-21-005911:0·
11 of 11 declarations
About Christensen Jamie
Jamie Christensen is the Executive Vice President and Chief Scientific Officer at Mirati Therapeutics, Inc. She oversees the company's research and development initiatives. Her role is essential for promoting scientific innovation.
